Results 191 to 200 of about 120,343 (298)
Analysis of Maternal Near-miss and Mortality with Hematologic Diseases in a Single Quaternary Referral Center in Southern Thailand. [PDF]
Peeyananjarassri K +5 more
europepmc +1 more source
KSHV/HHV8-mediated hematologic diseases.
Cesarman E, Chadburn A, Rubinstein PG.
europepmc +1 more source
We developed a nanoparticle named OAF, which simultaneously targeted to both the brain and liver via the transferrin receptor 1 (TfR1) receptor, promoting lipoprotein receptor‐related protein 1 (LRP1) expression to enhance amyloid‐beta (Aβ) clearance. In AD mice model, OAF significantly reduced Aβ deposition and cognitive impairment, while a mitigating
Wenshuai Gong +8 more
wiley +1 more source
Clinical Value of Tocilizumab in Reducing Mortality in Refractory Septic Shock in Children with Hematologic and Non-Hematologic Diseases. [PDF]
Lee EP +7 more
europepmc +1 more source
BCOR gene alterations in hematologic diseases.
Sportoletti P, Sorcini D, Falini B.
europepmc +1 more source
A bioactive hydrogel incorporating Chlorella vulgaris and paeoniflorin within a carboxymethyl chitosan/sodium alginate matrix cross‐linked with genipin is developed for inflammatory bowel disease therapy. The hydrogel exhibits gastric stability and intestine‐responsive release.
Jing Lu +8 more
wiley +1 more source
Sepsis‐associated encephalopathy (SAE) lacks effective therapies. We developed ME@FDsi, a biomimetic nanodrug using a tetrahedral framework nucleic acid to deliver disulfiram and siTNFα. It crosses the blood‐brain barrier, targets M1 microglia, inhibits pyroptosis and inflammation, and scavenges ROS.
Huimin Shi +15 more
wiley +1 more source
Adult AML with NUP98 rearrangements should be stratified into adverse-risk group
Wusixian Huang +6 more
doaj +1 more source
CEBPA double mutations associated with ABO antigen weakness in hematologic diseases. [PDF]
Choi SJ +6 more
europepmc +1 more source

